跳至主要内容
临床试验/CTRI/2024/02/063267
CTRI/2024/02/063267已完成2/3 期

A Randomized, Double Blind, Comparative, Multi-centric, Interventional, Prospective, Clinical study to Evaluate Efficacy & Safety of Topical head application Oil in participants with Stress & Insomnia

Dabur India Ltd3 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2024年3月11日最近更新:

试验速览

阶段
2/3 期
状态
已完成
入组人数
144
试验地点
3
主要终点
1. Change in stress level using perceived stress scale (PSS)

研究概览

简要总结

It is a randomized, double blind, comparative, multi-centric, interventional, prospective, clinical study to evaluate efficacy & safety of Topical head application Oil in participants with Stress and Insomnia. Study will be carried out in 3 to 4 centers in India. As per computer generated randomization list, participants will be randomized to one of the two study groups in 1:1 ratio. Participants will be asked to apply sufficient quantity of given oil on scalp in evening and thereafter head massage for 5 minutes for 14 days. Primary objectives of the study will be to assess change in stress level using perceived stress scale (PSS) and change in patient-reported total sleep time (as per Participant diary). Secondary objectives of the study will be to assess relaxation, cooling, refreshing, soothing (VAS) and time duration of relaxation, cooling, refreshing, soothing post application, change in sleep efficiency, Time to sleep onset. Number of awakenings, Wake time after sleep onset based on participant diary, change in fatigue using Fatigue Severity Scale (FSS), change in headache mood, ability to function at work, and concentration on a graded scale, change in severity of insomnia using Insomnia Severity Index (ISI), change in quality of sleep using Pittsburgh Sleep Quality Index (PSQI), change in hair fall through running finger test, comb test pull test and Dandruff test, change in quality of life (QOL) using Quality of Life Enjoyment and Satisfaction Questionnaire â€“ Short Form (Q-LES-Q-SF), changes in morning serum cortisol level, assessment of adverse events and vitals, global assessment for overall change by participants and by physician and post study tolerability of study product by participants and physician on day 0, day 7 and day 14.

Summary of Results:

The study concludes that topical use of DCO (DRDC/2024/009) for head message for a period of 14 days helps to reduce stress and fatigue and improve sleep onset, duration of sleep and sleep efficiency. DCO helped to impart relaxing, cooling (calming), refreshing and soothing effects, which was observed to be significantly better than control. The cooling (calming) refreshing and relaxation experience lasted for more than 8 hours. DCO also helped to reduce symptoms like headache and improve daytime mood, ability to function and concentration. Topical use of DCO to relieve the above symptoms was assessed to be safe.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Participants who perceive themselves to be under stress and having a score of between
  • 24 on the Perceived Stress Scale (PSS)
  • Participants with insomnia severity more than 7 and less than or equal to 21 on insomnia severity index
  • Participants willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

排除标准

  • Participants currently suffering from any known chronic physical, hormonal or psychiatric illness
  • Participants with uncontrolled diabetes and hypertension
  • Participants with substance dependence e.g. taking prohibited medications such as opium, cannabis (marijuana) and methamphetamines etc.
  • Chronic alcoholics and Habitual Tobacco chewers.
  • Known cases of severe/chronic hepatic or renal disease.
  • Known case of any active malignancy.
  • Participants with history of cardiovascular event less than 12 weeks prior to recruitment.
  • Participants having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  • Participants using any other investigational drug within 1 month prior to recruitment or participants currently participating in any other Clinical study
  • Known hypersensitivity to any of the ingredients used in study products
  • Participants with any current skin or scalp related medical or surgical condition
  • Pregnant and Lactating females.
  • Other conditions, which in the opinion of the investigators, make participant unsuitable for enrolment or could interfere with his/her participation and completion of the study.

结局指标

主要结局

1. Change in stress level using perceived stress scale (PSS)

时间窗: Day 0, Day 7 and Day 14

2. Change in patient-reported total sleep time (as per Participant diary)

时间窗: Day 0, Day 7 and Day 14

次要结局

  • 1. Assessment of relaxation, cooling, refreshing, soothing on VAS and time duration of relaxation, cooling, refreshing, soothing post application(2. Change in sleep efficiency, Time to sleep onset. Number of awakenings, Wake time after sleep onset)

研究者

申办方类型
Other [Healthcare Industry]
责任方
Principal Investigator
主要研究者

Dr Narendra B Mundhe

KVTR Ayurvedic College and Hospital Boradi

研究点 (3)

Loading locations...

相似试验